Organicell Regenerative Medicine, Inc. (BPSR) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Miami, FL, 美国. 现任CEO为 Albert Mitrani.
BPSR 拥有 IPO日期为 2022-01-31, 18 名全职员工, 在 Other OTC.
Organicell Regenerative Medicine, Inc. processes, distributes, and supplies biologically processed cellular and tissue-based products in the United States. The company was formerly known as Biotech Products Services and Research, Inc. and changed its name to Organicell Regenerative Medicine, Inc. in June 2018. Organicell Regenerative Medicine, Inc. has an agreement with Regenerative Care Network to study potential therapeutic benefits of Zofin for patients with heart failure. Organicell Regenerative Medicine, Inc. was founded in 2011 and is headquartered in Miami, Florida.
